IP Library Granted Patent US 9,763,991
Granted Patent B2
US 9,763,991 · App. 14/898,251 · Granted Sep 19, 2017

Composition for the treatment of neurobehavioral disorders

Inventors: Dorothy Helen Bray (Buckinghamshire, GB); Mario Lap (Amsterdam, NL); Alfredo Carlos Dupetit (Neunkirchen-Richelbach, DE)
Assignee: CANNABIS SCIENCE INTERNATIONAL HOLDING B.V.
A61K36/185A23L2/52A23L33/105A61K31/05A61K31/352A23V2002/00A61K36/752A61K2236/15
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,763,991
App. No.
14/898,251
Granted
Sep 19, 2017
Kind
B2
Abstract

The invention relates to a composition for use in the treatment of neurobehavioral disorders, a Cannabis plant extract comprising Cannabinol preferably with other constituents of this plant for such use and a method for the extraction of plants. The plants or plant parts may for instance be derived from Cannabis sativa and/or Cannabis indica and/or Cannabis ruderalis and/or citrus fruits, and mixtures thereof. The plant extracts derived showed particularly beneficial effects against sleeping disorders, in particular insomnia, and anxiety disorders including ADHD.

Claims (6)

1. A method of treating attention deficit hyperactivity disorder or chronic insomnia in a human in need thereof consisting essentially of administering a therapeutically effective amount of pure cannabinol to said human in need thereof to effectively treat the attention deficit hyperactivity disorder or chronic insomnia in the human in need thereof, wherein said pure cannabinol is obtained by isolation and purification from a natural source or by synthetic means.

2. The method of claim 1 , which treats attention deficit hyperactivity disorder in a human in need thereof.

3. The method of claim 1 , which treats chronic insomnia in a human in need thereof.

4. The method of claim 1 , wherein said pure cannabinol is obtained by synthetic means.

5. The method of claim 1 , wherein said pure cannabinol is obtained by isolation and purification from a natural source.

6. The method of claim 1 , wherein the administration is in the form of a powder, tablet or liquid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2017
From: LAP, MARIO
To: CANNABIS SCIENCE INTERNATIONAL HOLDING B.V.
Reel/Frame 043521/0524 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2017
From: BRAY, DOROTHY HELEN; DUPETIT, ALFREDO CARLOS
To: CANNABIS SCIENCE INTERNATIONAL HOLDING B.V.
Reel/Frame 043483/0440 →
Priority Claims (1)
NL 2010968 · Jun 13, 2013 · national
Continuity (1)
Related Publication 20160129060A1 · May 12, 2016